Clinical trial
Safety Study of Autologous Stem Cell in Liver Cirrhosis
NCT00382278 · Universidade Federal do Rio de Janeiro, Other · Terminated
Key facts
| NCT number | NCT00382278 |
|---|---|
| Title | Safety Study of Autologous Stem Cell in Liver Cirrhosis |
| Official title | Phase 1/2 Study of Autologous Bone Marrow Derived Mononuclear Cells in Liver Cirrhosis |
| Lead sponsor | Universidade Federal do Rio de Janeiro, Other |
| Collaborators | Financiadora de Estudos e Projetos |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cirrhosis |
| Intervention type | Procedure |
| Interventions | Autologous bone marrow-derived mononuclear cells infusion |
| Enrollment | 15 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Feb 1, 2008 |
| First posted | Sep 29, 2006 |
| Last update posted | Apr 3, 2008 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: